DarioHealth Corp. (DRIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 3M 6M 9M Q1 '13: 0 Q2 '13: 0 Q3 '13: 0 Q4 '13: 0 Q1 '14: 0 Q2 '14: 0 Q3 '14: 0 Q4 '14: 51K Q1 '15: 67K Q2 '15: 175K Q3 '15: 273K Q4 '15: 308K Q1 '16: 568K Q2 '16: 669K Q3 '16: 728K Q4 '16: 838K Q1 '17: 1M Q2 '17: 1.2M Q3 '17: 1.4M Q4 '17: 1.6M Q1 '18: 1.8M Q2 '18: 2.1M Q3 '18: 1.9M Q4 '18: 1.7M Q1 '19: 2.2M Q2 '19: 1.7M Q3 '19: 1.9M Q4 '19: 1.8M Q1 '20: 1.7M Q2 '20: 1.8M Q3 '20: 2M Q4 '20: 2.1M Q1 '21: 3.6M Q2 '21: 5.3M Q3 '21: 5.6M Q4 '21: 6M Q1 '22: 8.1M Q2 '22: 6.2M Q3 '22: 6.6M Q4 '22: 6.8M Q1 '23: 7.1M Q2 '23: 6.2M Q3 '23: 3.5M Q4 '23: 3.6M Q1 '24: 5.8M Q2 '24: 6.3M Q3 '24: 7.4M Q4 '24: 7.6M Q1 '25: 6.8M Q2 '25: 5.4M Q3 '25: 5M Q4 '25: 5.2M Q1 '26: 5.6M Q2 '26: 5.2M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Gross Profit Quarterly

-1.5M 0 1.5M 3M 4.5M Q1 '13: 0 Q2 '13: 0 Q3 '13: 0 Q4 '13: 0 Q1 '14: -421K Q2 '14: -605K Q3 '14: -585K Q4 '14: -1.1M Q1 '15: -230K Q2 '15: -235K Q3 '15: -131K Q4 '15: -259K Q1 '16: -102K Q2 '16: -157K Q3 '16: 76K Q4 '16: -647K Q1 '17: 106K Q2 '17: 360K Q3 '17: 276K Q4 '17: 569K Q1 '18: 552K Q2 '18: 522K Q3 '18: 468K Q4 '18: 223K Q1 '19: 558K Q2 '19: 326K Q3 '19: 873K Q4 '19: 840K Q1 '20: 779K Q2 '20: 636K Q3 '20: 549K Q4 '20: 549K Q1 '21: 1.1M Q2 '21: 1.5M Q3 '21: 826K Q4 '21: 548K Q1 '22: 4M Q2 '22: 1.1M Q3 '22: 1.8M Q4 '22: 2.7M Q1 '23: 3.2M Q2 '23: 2.1M Q3 '23: 610K Q4 '23: 132K Q1 '24: 2.4M Q2 '24: 2.8M Q3 '24: 3.9M Q4 '24: 4.2M Q1 '25: 3.9M Q2 '25: 3M Q3 '25: 3M Q4 '25: 2.8M Q1 '26: 3.2M Q2 '26: 3.2M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Operating Income Quarterly

-24M -16M -8M 0 8M 16M 24M Q1 '12: -494.7K Q2 '12: -866.3K Q3 '12: -1M Q4 '12: -1.6M Q1 '13: -3.1M Q2 '13: -3.6M Q3 '13: -3.2M Q4 '13: -3.7M Q1 '14: -2.7M Q2 '14: -3.6M Q3 '14: -2.5M Q4 '14: -2.6M Q1 '15: -1.8M Q2 '15: -1.5M Q3 '15: -2.5M Q4 '15: -1.9M Q1 '16: -1.9M Q2 '16: -2.6M Q3 '16: -2.7M Q4 '16: -3.8M Q1 '17: -4.2M Q2 '17: -4.1M Q3 '17: -3M Q4 '17: -3.1M Q1 '18: -2.9M Q2 '18: -5.8M Q3 '18: -4.1M Q4 '18: -4.9M Q1 '19: -5.4M Q2 '19: -5.4M Q3 '19: -2.8M Q4 '19: -4.2M Q1 '20: -10.1M Q2 '20: -4.1M Q3 '20: -6.6M Q4 '20: -9.1M Q1 '21: -14.3M Q2 '21: -18M Q3 '21: -22.5M Q4 '21: -21.7M Q1 '22: -15.9M Q2 '22: -17.4M Q3 '22: -14.6M Q4 '22: -9M Q1 '23: -12.4M Q2 '23: -14M Q3 '23: -15.5M Q4 '23: -14.2M Q1 '24: -17.9M Q2 '24: -16.2M Q3 '24: -12M Q4 '24: -11.7M Q1 '25: -9.4M Q2 '25: -9.2M Q3 '25: -9.5M Q4 '25: -8.6M Q1 '26: -7.3M Q2 '26: -6.5M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income Quarterly

-24M -16M -8M 0 8M 16M 24M Q1 '12: -570.9K Q2 '12: -867.2K Q3 '12: -3.1M Q4 '12: -1.2M Q1 '13: -5.2M Q2 '13: -5.3M Q3 '13: -3.5M Q4 '13: 54K Q1 '14: -3M Q2 '14: -3.3M Q3 '14: -3.1M Q4 '14: -3.6M Q1 '15: -1.6M Q2 '15: -2M Q3 '15: -1.8M Q4 '15: -1.7M Q1 '16: -2.4M Q2 '16: -4.1M Q3 '16: -611K Q4 '16: -3.9M Q1 '17: -5.4M Q2 '17: -4.1M Q3 '17: -3M Q4 '17: -3.3M Q1 '18: -2.9M Q2 '18: -5.8M Q3 '18: -4.1M Q4 '18: -5M Q1 '19: -5.4M Q2 '19: -5.4M Q3 '19: -2.8M Q4 '19: -4.2M Q1 '20: -9.9M Q2 '20: -4M Q3 '20: -6.5M Q4 '20: -9M Q1 '21: -15M Q2 '21: -17.8M Q3 '21: -22.4M Q4 '21: -21.6M Q1 '22: -15.9M Q2 '22: -18M Q3 '22: -15.6M Q4 '22: -12.6M Q1 '23: -12.8M Q2 '23: -16.6M Q3 '23: -15.7M Q4 '23: -14.3M Q1 '24: -7.2M Q2 '24: -13.6M Q3 '24: -12.3M Q4 '24: -9.6M Q1 '25: -9.2M Q2 '25: -13M Q3 '25: -10.5M Q4 '25: -9M Q1 '26: -8.2M Q2 '26: -7.9M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue Quarterly

0 2M 4M 6M Q1 '13: 0 Q2 '13: 0 Q3 '13: 0 Q4 '13: 0 Q1 '14: 421K Q2 '14: 605K Q3 '14: 585K Q4 '14: 663K Q1 '15: 297K Q2 '15: 410K Q3 '15: 404K Q4 '15: 567K Q1 '16: 670K Q2 '16: 826K Q3 '16: 652K Q1 '17: 901K Q2 '17: 850K Q3 '17: 1.1M Q4 '17: 1M Q1 '18: 1.2M Q2 '18: 1.5M Q3 '18: 1.4M Q4 '18: 1.5M Q1 '19: 1.7M Q2 '19: 1.3M Q3 '19: 995K Q4 '19: 958K Q1 '20: 888K Q2 '20: 1.2M Q3 '20: 1.5M Q4 '20: 1.5M Q1 '21: 2M Q2 '21: 3M Q3 '21: 4.8M Q4 '21: 5.5M Q1 '22: 4.1M Q2 '22: 5M Q3 '22: 4.8M Q4 '22: 4.1M Q1 '23: 3.9M Q2 '23: 4.1M Q3 '23: 2.9M Q4 '23: 3.5M Q1 '24: 3.3M Q2 '24: 3.5M Q3 '24: 3.5M Q4 '24: 3.4M Q1 '25: 2.9M Q2 '25: 2.4M Q3 '25: 2M Q4 '25: 2.4M Q1 '26: 2.4M Q2 '26: 2M Q4 '13 Q3 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Operating Cash Flow Quarterly

-21M -14M -7M 0 7M 14M 21M Q1 '12: -316K Q2 '12: -479.3K Q3 '12: -724K Q4 '12: -1.5M Q1 '13: -971.3K Q2 '13: -2.1M Q3 '13: -2.5M Q4 '13: -2.1M Q1 '14: -2.3M Q2 '14: -2.1M Q3 '14: -1.8M Q4 '14: -2.4M Q1 '15: -1.5M Q2 '15: -1.3M Q3 '15: -1.4M Q4 '15: -2.1M Q1 '16: -2.1M Q2 '16: -1.7M Q3 '16: -2.7M Q4 '16: -1.9M Q1 '17: -3.1M Q2 '17: -2.7M Q3 '17: -2.4M Q4 '17: -2.4M Q1 '18: -2.8M Q2 '18: -2M Q3 '18: -3.2M Q4 '18: -3.4M Q1 '19: -4M Q2 '19: -5.5M Q3 '19: -3.4M Q4 '19: -2.9M Q1 '20: -4.5M Q2 '20: -2.6M Q3 '20: -3.8M Q4 '20: -6.8M Q1 '21: -10.5M Q2 '21: -12.3M Q3 '21: -12.4M Q4 '21: -15.1M Q1 '22: -18.1M Q2 '22: -11.1M Q3 '22: -10.7M Q4 '22: -7.9M Q1 '23: -4.8M Q2 '23: -9.6M Q3 '23: -8.6M Q4 '23: -7.3M Q1 '24: -13.1M Q2 '24: -11.4M Q3 '24: -7.4M Q4 '24: -6.7M Q1 '25: -6.7M Q2 '25: -6M Q3 '25: -7.3M Q4 '25: -5.9M Q1 '26: -6M Q2 '26: -6.1M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-21M -14M -7M 0 7M 14M 21M Q1 '12: -325.5K Q2 '12: -491.8K Q3 '12: -735.6K Q4 '12: -2M Q1 '13: -1.4M Q2 '13: -2.7M Q3 '13: -2.6M Q4 '13: -2.2M Q1 '14: -2.5M Q2 '14: -2.1M Q3 '14: -1.8M Q4 '14: -2.8M Q1 '15: -1.6M Q2 '15: -1.3M Q3 '15: -1.4M Q4 '15: -2.1M Q1 '16: -2.1M Q2 '16: -1.9M Q3 '16: -2.9M Q4 '16: -2.3M Q1 '17: -3.1M Q2 '17: -2.8M Q3 '17: -2.4M Q4 '17: -2.5M Q1 '18: -2.8M Q2 '18: -2M Q3 '18: -3.3M Q4 '18: -3.5M Q1 '19: -4M Q2 '19: -5.5M Q3 '19: -3.4M Q4 '19: -2.9M Q1 '20: -4.6M Q2 '20: -2.7M Q3 '20: -3.8M Q4 '20: -6.8M Q1 '21: -10.6M Q2 '21: -12.3M Q3 '21: -12.5M Q4 '21: -15.2M Q1 '22: -18.2M Q2 '22: -11.3M Q3 '22: -10.9M Q4 '22: -8M Q1 '23: -4.8M Q2 '23: -9.8M Q3 '23: -8.9M Q4 '23: -7.4M Q1 '24: -13.2M Q2 '24: -11.4M Q3 '24: -7.4M Q4 '24: -6.8M Q1 '25: -6.7M Q2 '25: -6.1M Q3 '25: -7.4M Q4 '25: -5.9M Q1 '26: -6.1M Q2 '26: -6.1M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q1 '13: 14.8M Q2 '13: 18.3M Q3 '13: 4M Q1 '14: 21.4M Q2 '14: 23.2M Q3 '14: 9.6M Q2 '15: 30.2M Q3 '15: 37.4M Q2 '20: 4.1M Q3 '20: 7.3M Q1 '21: 14M Q2 '21: 15.7M Q3 '21: 16.5M Q1 '22: 19.6M Q2 '22: 22.4M Q3 '22: 23M Q1 '23: 27.6M Q2 '23: 28.2M Q3 '23: 28.8M Q1 '24: 34.4M Q2 '24: 39.8M Q3 '24: 2M Q1 '25: 2.4M Q2 '25: 2.5M Q3 '25: 3.1M Q1 '26: 6.6M Q2 '26: 9.3M Q3 '13 Q2 '15 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 0.00 6.00 12.00 18.00 Q4 '12: 0.47 Q1 '13: 0.17 Q2 '13: -0.05 Q3 '13: -0.65 Q4 '13: 3.10 Q1 '14: 3.31 Q2 '14: 3.45 Q3 '14: 3.64 Q4 '15: 5.75 Q1 '16: 6.37 Q2 '16: 5.71 Q3 '16: 5.61 Q4 '16: 1.98 Q1 '17: 2.00 Q2 '17: 2.30 Q3 '17: 2.15 Q4 '17: 1.56 Q1 '18: 2.11 Q2 '18: 2.22 Q3 '18: 2.35 Q4 '18: 15.61 Q1 '19: 12.89 Q2 '19: 10.71 Q3 '19: 9.77 Q4 '19: 6.99 Q1 '20: 8.34 Q2 '20: 10.16 Q3 '20: 10.56 Q4 '20: 4.00 Q1 '21: 6.49 Q2 '21: 8.16 Q3 '21: 10.05 Q4 '21: 4.18 Q1 '22: 4.00 Q2 '22: 3.75 Q3 '22: 3.21 Q4 '22: 2.64 Q1 '23: 2.35 Q2 '23: 2.19 Q3 '23: 2.04 Q4 '23: 1.93 Q1 '24: 1.68 Q2 '25: 13.21 Q3 '25: 11.26 Q4 '25: 10.44 Q1 '26: 8.82 Q2 '26: 6.13 Q4 '13 Q2 '16 Q4 '17 Q2 '19 Q4 '20 Q2 '22 Q4 '23 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.